Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in ...

Scientists found that a genetically engineered herpes simplex virus, when combined with immunotherapy, reduced or eliminated ...

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...

University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically ...

A virus once known for causing cold sores could potentially give cancer patients a fighting chance.

Modified Herpes Virus as a Weapon Against Skin Cancer? A new study suggests it might work—even for metastases deep within the ...

Effectiveness against both herpes zoster and postherpetic neuralgia remained stable for at least 4 years after vaccination.

This study has shown that HSV-1 is an "opportunistic interior designer" of human cells. | Genetics And Genomics ...